| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | SB 505124 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.6 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |